menu
    • menu

    Company profile for ReveraGen BioPharma

    NEW Drugs in Dev: 1
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a small clinical-stage drug development company with a focus on developing therapeutics for Duchenne muscular dystrophy. We run under a venture philanthropy model, through collaborations and partnerships with non-profit foundations and government agencies in both the US and the EU. As such, we keep the focus on stake holders rather than stock holders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ReveraGen BioPharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    155 Gibbs Street Suite 433 Rockville, MD 20850
    Telephone
    Telephone
    240-672-0295
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.reveragen.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Paris Packaging Week

    Paris Packaging Week

    Not Confirmed

    envelop Contact Supplier

    Paris Packaging Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Santhera and ReveraGen Announce FDA Acceptance of NDA for Vamorolone
    Santhera and ReveraGen Announce FDA Acceptance of NDA for Vamorolone

    09 Jan 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/01/09/2584775/0/en/Santhera-and-ReveraGen-Announce-FDA-Acceptance-of-New-Drug-Application-for-Vamorolone-in-Duchenne-Muscular-Dystrophy.html

    GLOBENEWSWIRE
    09 Jan 2023
    Share Share
    Penny stock forges ahead with an NDA for Duchenne, seeking priority review
    Penny stock forges ahead with an NDA for Duchenne, seeking priority review

    28 Oct 2022

    // Tyler Patchen ENDPTS

    https://endpts.com/penny-stock-forges-ahead-with-an-nda-for-duchenne-treatment/

    Tyler Patchen ENDPTS
    28 Oct 2022
    Share Share
    Santhera and ReveraGen Complete NDA Submission to FDA for Vamorolone
    Santhera and ReveraGen Complete NDA Submission to FDA for Vamorolone

    27 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/27/2542398/0/en/Santhera-and-ReveraGen-Complete-NDA-Submission-to-FDA-for-Vamorolone-in-Duchenne-Muscular-Dystrophy.html

    GLOBENEWSWIRE
    27 Oct 2022
    Share Share
    Santhera and ReveraGen Announce Presentations on Efficacy and Bone Health in DMD
    Santhera and ReveraGen Announce Presentations on Efficacy and Bone Health in DMD

    10 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/10/2530644/0/en/Santhera-and-ReveraGen-Announce-Presentations-on-Long-Term-Efficacy-and-Bone-Health-in-DMD-During-Vamorolone-Treatment-at-the-2022-World-Muscle-Society-Congress.html

    GLOBENEWSWIRE
    10 Oct 2022
    Share Share
    Santhera and ReveraGen Announce 1st Participant Dosed in FDA-funded PII study
    Santhera and ReveraGen Announce 1st Participant Dosed in FDA-funded PII study

    22 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/22/2501855/0/en/Santhera-and-ReveraGen-Announce-First-Participant-Dosed-in-FDA-funded-Phase-2-Pilot-Study-with-Vamorolone-in-Becker-Muscular-Dystrophy.html

    GLOBENEWSWIRE
    22 Aug 2022
    Share Share
    Santhera and ReveraGen to Present New Data with Vamorolone at 2022 PPMDC
    Santhera and ReveraGen to Present New Data with Vamorolone at 2022 PPMDC

    09 Jun 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/06/09/2459298/0/en/Santhera-and-ReveraGen-to-Present-New-Data-with-Vamorolone-at-2022-Parent-Project-Muscular-Dystrophy-Conference.html

    GLOBENEWSWIRE
    09 Jun 2022
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search